Biohaven (BHVN) EBT (2021 - 2026)
Biohaven (BHVN) reported EBT of -$130.3 million for Q1 2026, up 41.08% on a YoY basis from -$92.3 million in Q1 2025, and up 10.29% sequentially from -$145.2 million in Q4 2025.
Biohaven (BHVN) EBT (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of EBT data on file, last reported at -$130.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 41.08% year-over-year to -$130.3 million; the trailing twelve-month figure through Mar 2026 stood at -$646.6 million (up 27.17% YoY), and the FY2025 full-year result was -$737.4 million, up 12.81% from the prior year.
- EBT climbed to -$130.3 million in Q1 2026, from -$145.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$67.6 million in Q3 2022 to a low of -$319.6 million in Q2 2024.
- A 5-year average of -$158.4 million and a median of -$160.4 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT plunged 335.47% in 2022 and soared 55.28% in 2023, its largest moves.
- Tracing BHVN's EBT over 5 years: stood at -$215.2 million in 2022, then soared by 32.19% to -$146.0 million in 2023, then declined by 27.97% to -$186.8 million in 2024, then advanced by 22.27% to -$145.2 million in 2025, then climbed by 10.29% to -$130.3 million in 2026.
- Business Quant data shows BHVN's EBT at -$130.3 million in Q1 2026, -$145.2 million in Q4 2025, and -$173.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - | -130.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.26 Mn |
| Dec 31, 2025 | -145.20 Mn |
| Sep 30, 2025 | -173.22 Mn |
| Jun 30, 2025 | -197.89 Mn |
| Mar 31, 2025 | -221.07 Mn |
| Dec 31, 2024 | -186.80 Mn |
| Sep 30, 2024 | -160.36 Mn |
| Jun 30, 2024 | -319.59 Mn |
| Mar 31, 2024 | -178.94 Mn |
| Dec 31, 2023 | -145.97 Mn |
| Sep 30, 2023 | -105.86 Mn |
| Jun 30, 2023 | -88.17 Mn |
| Mar 31, 2023 | -69.55 Mn |
| Dec 31, 2022 | -215.25 Mn |
| Sep 30, 2022 | -67.64 Mn |
| Jun 30, 2022 | -197.18 Mn |
| Mar 31, 2022 | -89.78 Mn |
| Dec 31, 2021 | -49.43 Mn |
| Sep 30, 2021 | -55.50 Mn |